13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study

In 30–50% of patients with metastatic non-medullary thyroid cancer the metastases are not radioiodine-avid and so there is no effective treatment. Retinoids have demonstrated inhibition of thyroid tumor growth and induction of radioiodine uptake. The aim of our study was to assess benefits of the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Handkiewicz-Junak, Daria, Roskosz, Jozef, Hasse-Lazar, Kornelia, Szpak-Ulczok, Sylwia, Puch, Zbigniew, Kukulska, Aleksandra, Olczyk, Tomasz, Piela, Andrzej, Paliczka-Cieslik, Ewa, Jarzab, Barbara
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739165/
https://www.ncbi.nlm.nih.gov/pubmed/19646277
http://dx.doi.org/10.1186/1756-6614-2-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739165/
https://www.ncbi.nlm.nih.gov/pubmed/19646277
http://dx.doi.org/10.1186/1756-6614-2-8

Ejemplares similares